368 related articles for article (PubMed ID: 20682687)
1. Common variants in 40 genes assessed for diabetes incidence and response to metformin and lifestyle intervention in the diabetes prevention program.
Jablonski KA; McAteer JB; de Bakker PI; Franks PW; Pollin TI; Hanson RL; Saxena R; Fowler S; Shuldiner AR; Knowler WC; Altshuler D; Florez JC;
Diabetes; 2010 Oct; 59(10):2672-81. PubMed ID: 20682687
[TBL] [Abstract][Full Text] [Related]
2. Extension of type 2 diabetes genome-wide association scan results in the diabetes prevention program.
Moore AF; Jablonski KA; McAteer JB; Saxena R; Pollin TI; Franks PW; Hanson RL; Shuldiner AR; Knowler WC; Altshuler D; Florez JC;
Diabetes; 2008 Sep; 57(9):2503-10. PubMed ID: 18544707
[TBL] [Abstract][Full Text] [Related]
3. Genetic variation in the multidrug and toxin extrusion 1 transporter protein influences the glucose-lowering effect of metformin in patients with diabetes: a preliminary study.
Becker ML; Visser LE; van Schaik RH; Hofman A; Uitterlinden AG; Stricker BH
Diabetes; 2009 Mar; 58(3):745-9. PubMed ID: 19228809
[TBL] [Abstract][Full Text] [Related]
4. Association of genetic variation in the organic cation transporters OCT1, OCT2 and multidrug and toxin extrusion 1 transporter protein genes with the gastrointestinal side effects and lower BMI in metformin-treated type 2 diabetes patients.
Tarasova L; Kalnina I; Geldnere K; Bumbure A; Ritenberga R; Nikitina-Zake L; Fridmanis D; Vaivade I; Pirags V; Klovins J
Pharmacogenet Genomics; 2012 Sep; 22(9):659-66. PubMed ID: 22735389
[TBL] [Abstract][Full Text] [Related]
5. Lack of effect of the SLC47A1 and SLC47A2 gene polymorphisms on the glycemic response to metformin in type 2 diabetes mellitus patients.
Raj GM; Mathaiyan J; Wyawahare M; Priyadarshini R
Drug Metab Pers Ther; 2018 Dec; 33(4):175-185. PubMed ID: 30433870
[TBL] [Abstract][Full Text] [Related]
6. Effects of genetic variants previously associated with fasting glucose and insulin in the Diabetes Prevention Program.
Florez JC; Jablonski KA; McAteer JB; Franks PW; Mason CC; Mather K; Horton E; Goldberg R; Dabelea D; Kahn SE; Arakaki RF; Shuldiner AR; Knowler WC;
PLoS One; 2012; 7(9):e44424. PubMed ID: 22984506
[TBL] [Abstract][Full Text] [Related]
7. Genetic predictors of weight loss and weight regain after intensive lifestyle modification, metformin treatment, or standard care in the Diabetes Prevention Program.
Delahanty LM; Pan Q; Jablonski KA; Watson KE; McCaffery JM; Shuldiner A; Kahn SE; Knowler WC; Florez JC; Franks PW;
Diabetes Care; 2012 Feb; 35(2):363-6. PubMed ID: 22179955
[TBL] [Abstract][Full Text] [Related]
8. Identification of Genetic Variation Influencing Metformin Response in a Multiancestry Genome-Wide Association Study in the Diabetes Prevention Program (DPP).
Li JH; Perry JA; Jablonski KA; Srinivasan S; Chen L; Todd JN; Harden M; Mercader JM; Pan Q; Dawed AY; Yee SW; Pearson ER; Giacomini KM; Giri A; Hung AM; Xiao S; Williams LK; Franks PW; Hanson RL; Kahn SE; Knowler WC; Pollin TI; Florez JC;
Diabetes; 2023 Aug; 72(8):1161-1172. PubMed ID: 36525397
[TBL] [Abstract][Full Text] [Related]
9. Association of the SLC30A8 missense polymorphism R325W with proinsulin levels at baseline and after lifestyle, metformin or troglitazone intervention in the Diabetes Prevention Program.
Majithia AR; Jablonski KA; McAteer JB; Mather KJ; Goldberg RB; Kahn SE; Florez JC;
Diabetologia; 2011 Oct; 54(10):2570-4. PubMed ID: 21779873
[TBL] [Abstract][Full Text] [Related]
10. Variation in Maturity-Onset Diabetes of the Young Genes Influence Response to Interventions for Diabetes Prevention.
Billings LK; Jablonski KA; Warner AS; Cheng YC; McAteer JB; Tipton L; Shuldiner AR; Ehrmann DA; Manning AK; Dabelea D; Franks PW; Kahn SE; Pollin TI; Knowler WC; Altshuler D; Florez JC;
J Clin Endocrinol Metab; 2017 Aug; 102(8):2678-2689. PubMed ID: 28453780
[TBL] [Abstract][Full Text] [Related]
11. Testing of diabetes-associated WFS1 polymorphisms in the Diabetes Prevention Program.
Florez JC; Jablonski KA; McAteer J; Sandhu MS; Wareham NJ; Barroso I; Franks PW; Altshuler D; Knowler WC;
Diabetologia; 2008 Mar; 51(3):451-7. PubMed ID: 18060660
[TBL] [Abstract][Full Text] [Related]
12. Altered Glycemic Control Associated With Polymorphisms in the SLC22A1 (OCT1) Gene in a Mexican Population With Type 2 Diabetes Mellitus Treated With Metformin: A Cohort Study.
Reséndiz-Abarca CA; Flores-Alfaro E; Suárez-Sánchez F; Cruz M; Valladares-Salgado A; Del Carmen Alarcón-Romero L; Vázquez-Moreno MA; Wacher-Rodarte NA; Gómez-Zamudio JH
J Clin Pharmacol; 2019 Oct; 59(10):1384-1390. PubMed ID: 31012983
[TBL] [Abstract][Full Text] [Related]
13. Single nucleotide polymorphisms in genes encoding LKB1 (STK11), TORC2 (CRTC2) and AMPK alpha2-subunit (PRKAA2) and risk of type 2 diabetes.
Keshavarz P; Inoue H; Nakamura N; Yoshikawa T; Tanahashi T; Itakura M
Mol Genet Metab; 2008 Feb; 93(2):200-9. PubMed ID: 17950019
[TBL] [Abstract][Full Text] [Related]
14. Variation at the melanocortin 4 receptor gene and response to weight-loss interventions in the diabetes prevention program.
Pan Q; Delahanty LM; Jablonski KA; Knowler WC; Kahn SE; Florez JC; Franks PW;
Obesity (Silver Spring); 2013 Sep; 21(9):E520-6. PubMed ID: 23512951
[TBL] [Abstract][Full Text] [Related]
15. Statistical power considerations in genotype-based recall randomized controlled trials.
Atabaki-Pasdar N; Ohlsson M; Shungin D; Kurbasic A; Ingelsson E; Pearson ER; Ali A; Franks PW
Sci Rep; 2016 Nov; 6():37307. PubMed ID: 27886175
[TBL] [Abstract][Full Text] [Related]
16. AMPK Subunits Harbor Largely Nonoverlapping Genetic Determinants for Body Fat Mass, Glucose Metabolism, and Cholesterol Metabolism.
Randrianarisoa E; Lehn-Stefan A; Krier J; Böhm A; Heni M; Hrabě De Angelis M; Fritsche A; Häring HU; Stefan N; Staiger H
J Clin Endocrinol Metab; 2020 Jan; 105(1):. PubMed ID: 31512724
[TBL] [Abstract][Full Text] [Related]
17. Common variation at PPARGC1A/B and change in body composition and metabolic traits following preventive interventions: the Diabetes Prevention Program.
Franks PW; Christophi CA; Jablonski KA; Billings LK; Delahanty LM; Horton ES; Knowler WC; Florez JC;
Diabetologia; 2014 Mar; 57(3):485-90. PubMed ID: 24317794
[TBL] [Abstract][Full Text] [Related]
18. Association between organic cation transporter genetic polymorphisms and metformin response and intolerance in T2DM individuals: a systematic review and meta-analysis.
Peng A; Gong C; Xu Y; Liang X; Chen X; Hong W; Yan J
Front Public Health; 2023; 11():1183879. PubMed ID: 37546319
[TBL] [Abstract][Full Text] [Related]
19. A Protocol for the Study of Polymorphisms and Response to Metformin in Patients with Type 2 Diabetes in Trinidad.
Clement Y; Singh S; Motilal S; Maharaj R; Nunez-Smith M
Ethn Dis; 2020; 30(Suppl 1):211-216. PubMed ID: 32269463
[TBL] [Abstract][Full Text] [Related]
20. Adiponectin, change in adiponectin, and progression to diabetes in the Diabetes Prevention Program.
Mather KJ; Funahashi T; Matsuzawa Y; Edelstein S; Bray GA; Kahn SE; Crandall J; Marcovina S; Goldstein B; Goldberg R;
Diabetes; 2008 Apr; 57(4):980-6. PubMed ID: 18192541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
